The California Future of Abortion Council and the California Coalition for Reproductive Freedom have issued a statement in response to the U.S. Supreme Court hearing oral arguments today in Food and Drug Administration (FDA) v. Alliance for Hippocratic Medicine. Mifepristone remains approved, and its availability remains unchanged at least until SCOTUS rules, likely in June.
The organizations have issued the following statement:
“The California Future of Abortion Council and the California Coalition for Reproductive Freedom are committed to protecting the rights and health of every person in California and those seeking abortion care in our state. To be clear, abortion care, including medication abortion, remains legal and accessible in California. But the consequences of this case once a decision is issued could be incredibly far-reaching — and go as far as taking mifepristone entirely off the market nationwide — even in states like California where abortion is accessible and protected. Previous rulings in this case disregard decades of evidence proving the safety and efficacy of mifepristone and are part of a larger attempt by the anti-abortion movement to restrict reproductive care nationwide, causing undue harm to both patients and providers. We call on the U.S. Supreme Court to reject this outrageous attack on science, the FDA’s jurisdiction, and the fundamental ability of patients across the country to get the essential health care they want and need.”
